1 April 2024 false No description of principal activity Taxfiler 2024.6 05480714business:PrivateLimitedCompanyLtd2024-04-012025-03-31 054807142024-03-31 054807142024-04-012025-03-31 05480714business:AuditExempt-NoAccountantsReport2024-04-012025-03-31 05480714business:FilletedAccounts2024-04-012025-03-31 054807142025-03-31 05480714business:Director12024-04-012025-03-31 05480714business:Director22024-04-012025-03-31 05480714business:CompanySecretary12024-04-012025-03-31 05480714business:RegisteredOffice2024-04-012025-03-31 054807142024-03-31 05480714core:WithinOneYear2025-03-31 05480714core:WithinOneYear2024-03-31 05480714core:ShareCapitalcore:PreviouslyStatedAmount2025-03-31 05480714core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 05480714core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-03-31 05480714core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 05480714core:PreviouslyStatedAmount2025-03-31 05480714core:PreviouslyStatedAmount2024-03-31 05480714business:SmallEntities2024-04-012025-03-31 05480714countries:EnglandWales2024-04-012025-03-31 05480714core:PlantMachinery2024-04-012025-03-31 05480714core:PlantMachinery2024-03-31 05480714core:PlantMachinery2025-03-31 054807142023-04-012024-03-31 iso4217:GBP xbrli:pure
Company Registration No. 05480714 (England and Wales)
DAWAT PHARMA LIMITED Unaudited accounts for the year ended 31 March 2025
DAWAT PHARMA LIMITED Unaudited accounts Contents
Page
- 2 -
DAWAT PHARMA LIMITED Company Information for the year ended 31 March 2025
Directors
Tanveer Ahmed Usaamah Bin Ahmed
Secretary
Bushra Ahmed
Company Number
05480714 (England and Wales)
Registered Office
103 Broadway West Walsall WS1 4DW
Accountants
LINKTAX 11A Snow hill Shelton Stoke-on-Trent Staffordshire ST1 4LU
- 3 -
DAWAT PHARMA LIMITED Statement of financial position as at 31 March 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
7,028 
8,267 
Investments
125,000 
125,000 
132,028 
133,267 
Current assets
Debtors
183 
810 
Cash at bank and in hand
90,857 
161,328 
91,040 
162,138 
Creditors: amounts falling due within one year
(36,076)
(61,581)
Net current assets
54,964 
100,557 
Net assets
186,992 
233,824 
Capital and reserves
Called up share capital
1,000 
1,000 
Profit and loss account
185,992 
232,824 
Shareholders' funds
186,992 
233,824 
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 23 May 2025 and were signed on its behalf by
Tanveer Ahmed Director Company Registration No. 05480714
- 4 -
DAWAT PHARMA LIMITED Notes to the Accounts for the year ended 31 March 2025
1
Statutory information
DAWAT PHARMA LIMITED is a private company, limited by shares, registered in England and Wales, registration number 05480714. The registered office is 103 Broadway West, Walsall, WS1 4DW.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
20% reducing balance method
4
Tangible fixed assets
Plant & machinery 
£ 
Cost or valuation
At cost 
At 1 April 2024
23,120 
At 31 March 2025
23,120 
Depreciation
At 1 April 2024
14,853 
Charge for the year
1,239 
At 31 March 2025
16,092 
Net book value
At 31 March 2025
7,028 
At 31 March 2024
8,267 
- 5 -
DAWAT PHARMA LIMITED Notes to the Accounts for the year ended 31 March 2025
5
Investments
Other investments 
£ 
Valuation at 1 April 2024
125,000 
Valuation at 31 March 2025
125,000 
6
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
Trade debtors
- 
284 
Other debtors
183 
526 
183 
810 
7
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
VAT
8,873 
8,873 
Trade creditors
360 
360 
Taxes and social security
- 
158 
Other creditors
19,459 
- 
Loans from directors
6,604 
51,410 
Accruals
780 
780 
36,076 
61,581 
8
Average number of employees
During the year the average number of employees was 6 (2024: 6).
- 6 -